Related Experiment Videos
NF-kappaB, nitric oxide and opiate signaling
I D Welters1, C Fimiani, T V Bilfinger
1Department of Anesthesiology and Operative Intensive Care Medicine, Justus-Liebig-University Giessen, Giessen, Germany.
Medical Hypotheses
|May 3, 2000
Summary
Morphine modulates nuclear factor-kappaB (NF-kappaB) activation through nitric oxide signaling. This pathway is crucial for regulating inducible nitric oxide synthase expression and balancing nitric oxide production in cells.
Area of Science:
- Immunology
- Pharmacology
- Cellular Biology
Background:
- Nuclear factor-kappaB (NF-kappaB) is a key transcription factor involved in inflammatory cytokine activation.
- NF-kappaB activation is regulated by its inhibitor, IkappaBalpha, and is influenced by reactive oxygen species and calcium.
- Nitric oxide (NO) is known to inhibit NF-kappaB transcriptional activation in various cell types.
Purpose of the Study:
- To investigate the role of morphine in modulating NF-kappaB activation.
- To elucidate the signaling pathway involving morphine, nitric oxide, and NF-kappaB.
- To understand the regulation of inducible nitric oxide synthase (iNOS) expression.
Main Methods:
- The study focused on monocytes and endothelial cells.
- Investigated the effect of morphine on nitric oxide release.
- Examined the modulation of NF-kappaB activation via nitric oxide signaling.
Main Results:
- Morphine, acting through the mu3 opiate receptor, is linked to constitutive nitric oxide release.
- Morphine modulates NF-kappaB activation through a nitric oxide-dependent pathway.
- This pathway is critical for regulating inducible nitric oxide synthase (iNOS) expression.
Conclusions:
- Morphine's effect on NF-kappaB activation is mediated by nitric oxide.
- This mechanism plays a significant role in controlling the balance between constitutive and inducible nitric oxide synthase.
- Understanding this pathway offers insights into inflammatory responses and NO regulation.